Page 1

GENOVIS STORE AT + 4-8 ° C SmartEn SmartEnzymes ™ PH GENOVIS STORE AT + 4-8 ° C engvis.com STORE AT + 4-8 ° C FOR RESEARCH SmartEnzymes ™ GENOVIS STORE AT ● + 4-8 ° C ● FOR RESEARCH Second quarter 2021 Net sales rose by 26 % to SEK 19,535 ( 15,490 ) thousand . Growth is 37 % , adjusted for currency effects . Gross profit rose by 32 % to SEK 17,365 ( 13,146 ) thousand . 44-8C ( SEK 000S ) HALF - YEAR REPORT FOR THE FIRST HALF OF 2021 Net sales Gross profit Operating profit / loss ( EBIT ) Comprehensive income for the period Cash flow from operating activities Cash and cash equivalents at close of period Earnings per share * ( SEK ) Operating profit before depreciation and amortization ( EBITDA ) totaled SEK 2,793 ( loss : 38 ) thousand . April - June 2021 19,535 15,490 2020 17,365 13,146 1,350 -1,291 1,033 -1,747 41,730 0.01 Operating profit improved by SEK 2,641 thousand and totaled SEK 1,350 ( loss : 1,291 ) thousand . -3,123 -123 Comprehensive income for the period improved by SEK 4,156 thousand and totaled SEK 1,033 ( loss : 3,123 ) thousand . Comprehensive income per share , basic and diluted , totaled SEK 0.01 ( -0.02 ) . Cash flow from operating activities was SEK -1,747 ( -123 ) thousand . Cash and cash equivalents at the end of the period totaled SEK 41,730 ( 46,554 ) thousand . 46,554 -0.02 Jan. - June 2021 2020 35,258 26,965 32,382 24 , 123 1,901 -3,180 2,640 -5,038 1,765 -1,629 41,730 46,554 0.02 -0.05 SmartEnzymes ™ full - yea STORE AT + 4-8 ° C 2020 FOR RESEARCH 61,030 59,370 3,140 1,973 3,755 GENOVIS 44,118 0.10 STORE AT + 4-8 ° C deGlycIT ™ Smar deGlycIT ™